investorscraft@gmail.com

Intrinsic ValueNantong Jiangshan Agrochemical & Chemicals Co.,Ltd. (600389.SS)

Previous Close$27.42
Intrinsic Value
Upside potential
Previous Close
$27.42

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Nantong Jiangshan Agrochemical & Chemicals operates as a diversified chemical manufacturer specializing in agricultural solutions and industrial chemicals. The company generates revenue through the production and distribution of herbicides, insecticides, and fungicides, serving China's extensive agricultural sector while also manufacturing resins, chlorine-caustic sodium, and fine chemicals for industrial applications. Its product portfolio includes glyphosate-based herbicides and specialized insecticides like dichlorvos and imidaclothiz, positioning it within the competitive agrochemical landscape. The company maintains international reach by exporting to 40 countries across Asia, Europe, the Americas, and Africa, demonstrating global market penetration beyond its domestic base. This export capability provides revenue diversification while leveraging China's manufacturing advantages. The company further expands its market position through production of intermediate chemicals and advanced materials including microporous insulating boards and flame retardant products, creating multiple revenue streams across different chemical sub-sectors.

Revenue Profitability And Efficiency

The company reported revenue of CNY 5.43 billion with net income of CNY 224.4 million, indicating a net margin of approximately 4.1%. Operating cash flow of CNY 347.2 million demonstrates reasonable cash generation from core operations. The capital expenditure of CNY -1.26 billion suggests significant investment in capacity expansion or modernization projects during the period.

Earnings Power And Capital Efficiency

Diluted EPS of CNY 0.52 reflects the company's earnings capacity relative to its equity base. The substantial capital expenditure program indicates management's focus on long-term growth investments, though this has temporarily impacted free cash flow generation. The company maintains operational cash flow sufficient to support its strategic investments while funding ongoing operations.

Balance Sheet And Financial Health

The balance sheet shows CNY 1.13 billion in cash against total debt of CNY 1.51 billion, indicating moderate leverage. The cash position provides liquidity for operational needs and debt servicing. The debt level appears manageable given the company's cash generation capacity and market position in the chemical sector.

Growth Trends And Dividend Policy

The company paid a dividend of CNY 0.10 per share, representing a payout ratio of approximately 19% based on diluted EPS. This balanced approach returns capital to shareholders while retaining earnings for reinvestment. The significant capital expenditure suggests management is prioritizing growth initiatives alongside shareholder returns.

Valuation And Market Expectations

With a market capitalization of CNY 11.0 billion and a beta of 0.72, the market prices the company with lower volatility than the broader market. The valuation reflects expectations for stable performance in the agricultural chemical sector, though specific growth assumptions are not explicitly detailed in available data.

Strategic Advantages And Outlook

The company benefits from its diversified chemical portfolio and international export capabilities, providing resilience against regional market fluctuations. Its position in agricultural chemicals aligns with food security needs, while industrial chemical products offer additional growth avenues. The ongoing capital investments suggest confidence in future demand across its product segments.

Sources

Company financial reportsStock exchange disclosuresMarket data providers

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount